Effectiveness of the Noveko(TM) Antimicrobial Face Mask against the Human Influenza A Virus (H1N1)



    Symbol: EKO / TSX

    MONTREAL, May 12 /CNW Telbec/ - Noveko International Inc. ("the Company")
announces that it has received preliminary results of tests conducted by
Microbiotest Lab, an independent laboratory located in Sterling, Virginia,
USA, on the Noveko(TM) antimicrobial masks with respect to the Influenza A
Virus (H1N1) similar to the one responsible for the human swine flu. The
purpose of these tests was to evaluate the effectiveness of Noveko(TM) face
mask materials to inactivate this virus on direct contact and to simulate the
use of the face mask by a user. The preliminary results have demonstrated a
bio-efficacy of a Log 3 Reduction over a period of 30 minutes.
    "These preliminary results are very encouraging since they show the
effectiveness of our masks to inactivate the Human Influenza A Virus (H1N1) at
99.9% over a period of 30 minutes. Even if the spread of the human swine flu
currently appears to be in a declining phase, many scientists fear a more
severe outbreak in fall. We thus anticipate that our sales of face masks and
of our AZURO(TM) antiseptic disinfectants should increase in the next few
months", stated Mr. Alain Bolduc, President and Chief Operating Officer of the
Company.

    Profile

    Noveko International Inc. offers innovative solutions worldwide in the
biomedical and environmental fields. The Company, through its subsidiaries,
specializes in the following business segments: the development and marketing
of products derived from its patented antimicrobial filtration technology,
primarily air filters, surgical masks and respirators, as well as other
antimicrobial products such as AZURO(TM) disinfectants and - the development,
manufacturing and marketing of medical equipment, primarily portable real-time
ultrasound scanners for use in human and veterinary medicine.

    Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are identified by
the use of terms such as "may", "could", "might", "intend", "should",
"expect", "project", "plan", "believe", "estimate" or other comparable
variants. These statements are based on the information available at the time
they are written, on assumptions made by management and on the expectations of
management, acting in good faith, regarding future events, including those
relating to economic conditions, fluctuations in exchange rates and operating
expenses, and the absence of unusual events entailing supplementary
expenditures. Although management considers these assumptions and expectations
reasonable based on the information available at the time they are written,
they could prove inaccurate. Forward-looking statements are also subject, by
their very nature, to known and unknown risks and uncertainties such as those
related to the industry, acquisitions, labor relations, credit, key officers,
supply and product liability. The actual results of Noveko International Inc.
could differ materially from those indicated or underlying these
forward-looking statements. The reader is therefore recommended not to unduly
rely on these forward-looking statements. Forward-looking statements do not
reflect the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. The Company undertakes no obligation to update or revise the
forward-looking statements to account for new events or new circumstances,
except where provided for by applicable legislation.




For further information:

For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606,
http://www.noveko.com

Organization Profile

Noveko International Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890